(600196)"Shanghai Fosun Pharmaceutical (Group) Co., Ltd."Announcement on Progress in Providing Guarantees for Controlled Subsidiaries
Filed with SSE · Stock code 600196 · · 19 pages · Chinese
Summary by 6ix AI
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has announced progress regarding guarantees provided for its controlled subsidiaries. The filing outlines the details of various guarantee agreements made with banks to support financing for these subsidiaries. It also includes information on the total amount of guarantees provided and the internal decision-making processes followed for these agreements. As of mid-October, the company reported no overdue guarantees and detailed the necessity and rationale behind these guarantees.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. on 6ix
Story so far
- (600196)"Shanghai Fosun Pharmaceutical (Group) Co., Ltd."Announcement on Results of Reserved Grant under the 2025 A-Share Stock Option Incentive Plan
- Announcement on Signing of Cooperation and License Agreement by Controlled Subsidiary
- Announcement on Release of Pledge of Certain Shares Held by Shareholder
Earlier from Shanghai Fosun Pharmaceutical (Group)
- (600196)"Shanghai Fosun Pharmaceutical (Group) Co., Ltd."Announcement on Results of Reserved Grant under the 2025 A-Share Stock Option Incentive Plan
- A New International Medical Approach Aimed at Reversing Diabetes has Officially Launched in Shenzhen, China
- Announcement on Signing of Cooperation and License Agreement by Controlled Subsidiary
- Announcement on Release of Pledge of Certain Shares Held by Shareholder
- Fosun Health Anjur Forum Rawatan Onkologi Antarabangsa Pertama di Foshan; International Oncology Alliance Ditubuhkan Secara Rasmi
Follow Shanghai Fosun Pharmaceutical (Group) into a list and get an email when it puts out news.
Follow Shanghai Fosun Pharmaceutical (Group)